Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 25;38(1):e101794.
doi: 10.1136/gpsych-2024-101794. eCollection 2025.

Findings from a social media listening study on Chinese patients with Alzheimer's disease: a content analysis

Affiliations

Findings from a social media listening study on Chinese patients with Alzheimer's disease: a content analysis

Nan Zhi et al. Gen Psychiatr. .

Abstract

Background: Social media listening is a new approach for gathering insights from social media platforms about users' experiences. This approach has not been applied to analyse discussions about Alzheimer's disease (AD) in China.

Aims: We aimed to leverage multisource Chinese data to gain deeper insights into the current state of the daily management of Chinese patients with AD and the burdens faced by their caregivers.

Methods: We searched nine mainstream public online platforms in China from September 2010 to March 2024. Natural language processing tools were used to identify patients and caregivers, and categorise patients by disease stage for further analysis. We analysed the current state of patient daily management, including diagnosis and treatment, choice of treatment scenarios, patient safety and caregiver concerns.

Results: A total of 1211 patients with AD (66% female, 82% aged 60-90) and 756 caregivers for patients with AD were identified from 107 556 online sources. Most patients were derived from online consultation platforms (43%), followed by bulletin board system platforms (24%). Among the patients categorised into specific disease stages (n=382), 42% were in the moderate stage. The most frequent diagnostic tools included medical history (97%) and symptoms (84%). Treatment options for patients with AD primarily included cholinesterase inhibitors, N-methyl-D-aspartate receptor antagonists and antipsychotics. Both quantitative and qualitative analysis of patients who experienced wandering (n=92) indicated a higher incidence of wandering during the moderate stage of the disease. Most caregivers were family members, with their primary concerns focusing on disease management and treatment (90%), followed by daily life care (37%) and psychosocial support (25%).

Conclusions: Online platform data provide a broad spectrum of real-world insights into individuals affected by AD in China. This study enhances our understanding of the experiences of patients with AD and their caregivers, providing guidance for developing personalised interventions, providing advice for caregivers and improving care for patients with AD.

Keywords: cognition disorders.

PubMed Disclaimer

Conflict of interest statement

YZ is an employee of Lundbeck (Beijing) Pharmaceutical Consulting. Other authors declare that they have no competing interests.

Figures

Figure 1
Figure 1. Flowchart of stakeholder identification and platform type from which online text was extracted. *Patient information was identified first, and caregiver information was then extracted from the patient-related text based on whether the caregiver perspective exists. AD, Alzheimer’s disease; BBS, bulletin board system.
Figure 2
Figure 2. Overall workflow and algorithm tools used in the study. *Experts will conduct manual checks on the analytical results. AD, Alzheimer’s disease; BBS, bulletin board system; NER, named-entity recognition; LLMs, large language models.
Figure 3
Figure 3. Reasons for patients’ treatment switch in different disease stages. ‘Other factors’ refers to the patient mentioning changes in treatment without specifying the reasons.
Figure 4
Figure 4. Caregiver topics of concern.

References

    1. Zhang H-G, Fan F, Zhong B-L, et al. Relationship between left-behind status and cognitive function in older Chinese adults: a prospective 3-year cohort study. Gen Psychiatr. 2023;36:e101054. doi: 10.1136/gpsych-2023-101054. - DOI - PMC - PubMed
    1. Ren R, Qi J, Lin S, et al. The China Alzheimer report 2022. Gen Psychiatr. 2022;35:e100751. doi: 10.1136/gpsych-2022-100751. - DOI - PMC - PubMed
    1. Wang H, Xie H, Qu Q, et al. The continuum of care for dementia: needs, resources and practice in China. J Glob Health. 2019;9:020321. doi: 10.7189/jogh.09.020321. - DOI - PMC - PubMed
    1. Jia J, Zuo X, Jia X-F, et al. Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China. Alzheimers Dement. 2016;12:446–53. doi: 10.1016/j.jalz.2015.06.1892. - DOI - PubMed
    1. Zhao W, Jones C, Wu M-LW, et al. Healthcare professionals’ dementia knowledge and attitudes towards dementia care and family carers’ perceptions of dementia care in China: an integrative review. J Clin Nurs. 2022;31:1753–75. doi: 10.1111/jocn.15451. - DOI - PubMed

LinkOut - more resources